ConductScience.org, home

Paper35856448

Combining TMZ and SB225002 induces changes of CXCR2 and VEGFR signalling in primary human endothelial cells in vitro.

Urbantat RM and 4 others. Oncol Rep, 2022. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Combining TMZ and SB225002 induces changes of CXCR2 and VEGFR signalling in primary human endothelial cells in vitro. Papers, record 35856448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35856448

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combining TMZ and SB225002 induces changes of CXCR2 and VEGFR signalling in primary human endothelial cells in vitro.
PubMed
Journal
Oncol Rep
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2022-08-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Urbantat RMRuth M
2Jelgersma CClaudius
3Vajkoczy PPeter
4Brandenburg SSusan
5Acker GGueliz

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Endothelial CellsMajor topic
GlioblastomaMajor topic
Humans
Interleukin-8
Phenylurea Compounds
Proto-Oncogene Proteins c-bcl-2
Receptors, Interleukin-8B
Temozolomide
Vascular Endothelial Growth Factor A

Source PubMed

Download CSV of topics

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128407030Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.Ann Oncol2017https://conductscience.org/library/papers/28407030PubMed
230236892CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma.Neoplasia2018https://conductscience.org/library/papers/30236892PubMed
320652010CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells.J Oncol2010https://conductscience.org/library/papers/20652010PubMed
419509115K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways.Mol Cancer Res2009https://conductscience.org/library/papers/19509115PubMed
528367602Myeloid cells expressing high level of CD45 are associated with a distinct activated phenotype in glioma.Immunol Res2017https://conductscience.org/library/papers/28367602PubMed
616540656A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer.Cancer Res2006https://conductscience.org/library/papers/16540656PubMed
723611835Molecular mechanisms of the antitumor activity of SB225002: a novel microtubule inhibitor.Biochem Pharmacol2013https://conductscience.org/library/papers/23611835PubMed
832709985mRNAs, proteins and the emerging principles of gene expression control.Nat Rev Genet2020https://conductscience.org/library/papers/32709985PubMed
925658639Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.PLoS One2015https://conductscience.org/library/papers/25658639PubMed
1033640445Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors.Semin Cancer Biol2022https://conductscience.org/library/papers/33640445PubMed
1118841047Antiangiogenic therapy in malignant gliomas.Curr Opin Oncol2008https://conductscience.org/library/papers/18841047PubMed
1224582495Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma.Surgery2014https://conductscience.org/library/papers/24582495PubMed
1326792871Differential dynamics of the mammalian mRNA and protein expression response to misfolding stress.Mol Syst Biol2016https://conductscience.org/library/papers/26792871PubMed
1414632748Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration.Clin Exp Immunol2003https://conductscience.org/library/papers/14632748PubMed
1534681839Tumor-Associated Microglia/Macrophages as a Predictor for Survival in Glioblastoma and Temozolomide-Induced Changes in CXCR2 Signaling with New Resistance Overcoming Strategy by Combination Therapy.Int J Mol Sci2021https://conductscience.org/library/papers/34681839PubMed
1634203660Advances in Chemokine Signaling Pathways as Therapeutic Targets in Glioblastoma.Cancers (Basel)2021https://conductscience.org/library/papers/34203660PubMed
1732157552Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis.J Neurooncol2020https://conductscience.org/library/papers/32157552PubMed
1815617481The role of VEGF in the regulation of physiological and pathological angiogenesis.EXS2005https://conductscience.org/library/papers/15617481PubMed
1925682075Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists.Breast Cancer Res Treat2015https://conductscience.org/library/papers/25682075PubMed
2031316566Chemotherapeutic Stress Induces Transdifferentiation of Glioblastoma Cells to Endothelial Cells and Promotes Vascular Mimicry.Stem Cells Int2019https://conductscience.org/library/papers/31316566PubMed

See all 57 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41155662Direct Targeting of CXCR2 Receptor Inhibits Neuroblastoma Growth: An In Vitro Assessment.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41155662PubMed
40808496Anti-Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin-1 Pathway.Cancer Med2025https://conductscience.org/library/papers/40808496PubMed
38713320Crosstalk between cancer cells and macrophages promotes OSCC cell migration and invasion through a CXCL1/EGF positive feedback loop.Discov Oncol2024https://conductscience.org/library/papers/38713320PubMed
38069130
CXCR2-Blocking Has Context-Sensitive Effects on Rat Glioblastoma Cell Line Outgrowth (S635) in an Organotypic Rat Brain Slice Culture Depending on Microglia-Depletion (PLX5622) and Dexamethasone Treatment.
Int J Mol Sci2023https://conductscience.org/library/papers/38069130PubMed
37686093Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes.Int J Mol Sci2023https://conductscience.org/library/papers/37686093PubMed
36980182Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies.Cells2023https://conductscience.org/library/papers/36980182PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35856448

GET https://conductscience.org/api/papers/v1/35856448/references?page=2